Luanna taifid
Lua APA (7ú heag.)
Collaborators, t. N. E. S. (2025). Effectiveness of catch-up and at-birth nirsevimab immunisation against RSV hospital admission in the first year of life: A population-based case–control study, Spain, 2023/24 season. European Centre for Disease Prevention and Control.
Cóipeáladh chuig an ngearrthaisce go rathúil é
Níorbh fhéidir cóipeáil chuig an ngearrthaisce
Lua i Stíl Chicago (17ú heag.)
Collaborators, the Nirsevimab Effectiveness Study. Effectiveness of Catch-up and At-birth Nirsevimab Immunisation Against RSV Hospital Admission in the First Year of Life: A Population-based Case–control Study, Spain, 2023/24 Season. European Centre for Disease Prevention and Control, 2025.
Cóipeáladh chuig an ngearrthaisce go rathúil é
Níorbh fhéidir cóipeáil chuig an ngearrthaisce
Lua MLA (9ú heag.)
Collaborators, the Nirsevimab Effectiveness Study. Effectiveness of Catch-up and At-birth Nirsevimab Immunisation Against RSV Hospital Admission in the First Year of Life: A Population-based Case–control Study, Spain, 2023/24 Season. European Centre for Disease Prevention and Control, 2025.
Cóipeáladh chuig an ngearrthaisce go rathúil é
Níorbh fhéidir cóipeáil chuig an ngearrthaisce
Rabhadh: Seans nach mbeach na luanna seo go hiomlán cruinn i ngach uile chás.